Surmodics | SRDX - Umsatzkosten





Umsatzkosten Veränderung Datum
Abbott USD 5.3B 380M 2026-03
Align Technology USD 303.5M 60.47M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Artivion USD 42.85M 3.86M 2025-12
Baxter International USD 1.81B 587M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
EDAP TMS EUR 7.91M 1.31M 2025-09
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Haemonetics USD 136.58M 4.01M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
J&J USD 8.07B 103M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Mesa Laboratories USD 21.92M 1.78M 2024-09
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Option Care Health USD 1.1B 98.26M 2026-03
Stryker USD 2.36B 325M 2026-03
Surmodics USD 9.49M 23.54M 2025-06
Trinity Biotech USD 7.84M 3.14M 2025-09